Literature DB >> 12420105

Natural killer and natural killer-T cells in psoriasis.

A L Cameron1, B Kirby, W Fei, C E M Griffiths.   

Abstract

Psoriasis is characterized by a dermal and epidermal infiltrate comprised predominantly of CD4(+) and CD8(+) T cells, respectively. These cells behave in an antigen-dependent manner, which suggests that psoriasis may be a T-cell-mediated autoimmune disease. Psoriasis shares certain immunological features with recognized autoimmune conditions such as type I diabetes mellitus and multiple sclerosis, in both of which a pathogenic role is postulated for natural killer (NK) cells and natural killer-like T (NK-T) cells. However, there are few studies assessing the role of NK and NK-T cells in psoriasis. We sought to determine whether NK and NK-T cells are present in psoriasis. Skin biopsies were taken from the active edge of a psoriasis plaque and from uninvolved skin at least 5 cm away from involved skin of ten patients with chronic plaque psoriasis. Skin from four normal subjects was used as controls. Using an immunoperoxidase technique, cryostat sections were stained using antibodies to T-cell markers CD2, CD3, CD4 and CD8; cutaneous leucocyte associated antigen; NK cell markers CD16, CD56, CD57, CD94 and CD158a; and the NK-T cell marker CD161. There were significantly more cells expressing T cell markers, NK cell markers CD16, CD57, CD94 and CD158a and NK-T cell marker CD161 in involved skin than in uninvolved or normal skin ( P<0.01). There was no difference in the number of cells expressing CD56. Cells expressing NK markers were found most commonly in the papillary dermis immediately subjacent to the dermoepidermal junction. Cells expressing CD57 were found in significantly higher numbers in the epidermis and reticular dermis of involved skin. This study demonstrates that cells expressing NK markers and NK-T cell markers are present in plaques of psoriasis. The exact roles of NK and NK-T cells in psoriasis are unclear, although they may modulate autoimmune inflammation and act as a source of Th(1) cytokines important in the psoriatic process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12420105     DOI: 10.1007/s00403-002-0349-4

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  21 in total

1.  Characterization of chicken epidermal dendritic cells.

Authors:  Botond-Zoltán Igyártó; Erzsébet Lackó; Imre Oláh; Attila Magyar
Journal:  Immunology       Date:  2006-08-04       Impact factor: 7.397

Review 2.  Molecular mechanisms of mechanotransduction in psoriasis.

Authors:  Lina S Malakou; Antonios N Gargalionis; Christina Piperi; Evangelia Papadavid; Athanasios G Papavassiliou; Efthimia K Basdra
Journal:  Ann Transl Med       Date:  2018-06

3.  Characterization of the immune status of CD8+ T cells in oral lesions of human immunodeficiency virus-infected persons with oropharyngeal Candidiasis.

Authors:  Janet E Leigh; Kelly M McNulty; Paul L Fidel
Journal:  Clin Vaccine Immunol       Date:  2006-06

4.  Activation of keratinocyte protein kinase C zeta in psoriasis plaques.

Authors:  Yuming Zhao; Rita Fishelevich; John P Petrali; Lida Zheng; Malinina Alla Anatolievna; April Deng; Richard L Eckert; Anthony A Gaspari
Journal:  J Invest Dermatol       Date:  2008-04-03       Impact factor: 8.551

5.  IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation.

Authors:  Hak-Ling Ma; Spencer Liang; Jing Li; Lee Napierata; Tom Brown; Stephen Benoit; Mayra Senices; Davinder Gill; Kyriaki Dunussi-Joannopoulos; Mary Collins; Cheryl Nickerson-Nutter; Lynette A Fouser; Deborah A Young
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

6.  Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.

Authors:  P H Schafer; A Parton; A K Gandhi; L Capone; M Adams; L Wu; J B Bartlett; M A Loveland; A Gilhar; Y-F Cheung; G S Baillie; M D Houslay; H-W Man; G W Muller; D I Stirling
Journal:  Br J Pharmacol       Date:  2009-12-24       Impact factor: 8.739

7.  Human natural killer T cells infiltrate into the skin at elicitation sites of allergic contact dermatitis.

Authors:  Michael D Gober; Rita Fishelevich; Yuming Zhao; Derya Unutmaz; Anthony A Gaspari
Journal:  J Invest Dermatol       Date:  2007-12-13       Impact factor: 8.551

8.  Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis.

Authors:  A E Hogan; A M Tobin; T Ahern; M A Corrigan; G Gaoatswe; R Jackson; V O'Reilly; L Lynch; D G Doherty; P N Moynagh; B Kirby; J O'Connell; D O'Shea
Journal:  Diabetologia       Date:  2011-07-09       Impact factor: 10.122

9.  CD57 expression and cytokine production by T cells in lesional and unaffected skin from patients with psoriasis.

Authors:  Mariana D Batista; Camilla Tincati; Jeffrey M Milush; Emily L Ho; Lishomwa C Ndhlovu; Vanessa A York; Esper G Kallas; Jorge Kalil; Sheila M Keating; Philip J Norris; David Chang; Patrick Unemori; Kieron S Leslie; Toby Maurer; Wilson Liao; Douglas F Nixon
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

Review 10.  New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast.

Authors:  Andrew C Palfreeman; Kay E McNamee; Fiona E McCann
Journal:  Drug Des Devel Ther       Date:  2013-03-27       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.